Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is Immediate Lymphatic Reconstruction Cost-Effective for Breast Cancer Lymphedema?

Plastic and reconstructive surgery·2026
Same author

Missing, But Not Forgotten: Commission on Cancer Center Accreditation and the Impact of Missing Data in Surveillance, Epidemiology, and End Results Studies.

Journal of the American College of Surgeons·2026
Same author

Age-Based Left-Digit Bias in the Treatment of Pancreatic Adenocarcinoma.

Journal of gastrointestinal cancer·2026
Same author

Women Going Forward in Survival (Mujeres Avanzando a la Sobrevida): A Prospective Breast Cancer Cohort Study in Honduras.

JCO global oncology·2026
Same author

Using Group Concept Mapping to Define Priorities for Lymphedema Care and Research.

Lymphatic research and biology·2025
Same author

Gene Expression Profile-Based Test to Predict Melanoma Sentinel Node Status: The MERLIN_001 Study.

JAMA surgery·2025

Related Experiment Video

Updated: May 3, 2026

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

1.5K

Contralateral prophylactic mastectomy: are we overtreating patients?

Erin E Burke1, Pamela R Portschy, Todd M Tuttle

  • 1Department of Surgery, University of Minnesota, 420 Delaware St SE, MMC 195, Minneapolis, MN 55455, USA.

Expert Review of Anticancer Therapy
|February 15, 2014
PubMed
Summary

Women with unilateral breast cancer face higher contralateral breast cancer risk. Contralateral prophylactic mastectomy (CPM) rates are rising, prompting analysis of trends, patient choices, outcomes, and informed decision-making.

More Related Videos

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
13:35

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

5.8K
Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery
11:49

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery

Published on: April 3, 2026

454

Related Experiment Videos

Last Updated: May 3, 2026

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

1.5K
Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
13:35

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

5.8K
Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery
11:49

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery

Published on: April 3, 2026

454

Area of Science:

  • Oncology
  • Surgical Oncology
  • Public Health

Background:

  • Patients diagnosed with unilateral breast cancer exhibit an elevated risk of developing secondary malignancy in the contralateral breast.
  • Recent years have witnessed a significant increase in contralateral prophylactic mastectomy (CPM) rates across the United States.
  • Understanding the drivers behind this trend is crucial for patient care and resource allocation.

Discussion:

  • This article examines current trends in CPM utilization, exploring the multifaceted reasons influencing patient decisions.
  • It critically evaluates the post-operative outcomes associated with CPM and discusses alternative risk-management strategies.
  • A key focus is assessing the adequacy of patient information regarding CPM and its implications.

Key Insights:

  • Rising CPM rates suggest a growing patient interest in proactive risk reduction for contralateral breast cancer.
  • Patient motivations for CPM are diverse, encompassing risk perception, survival expectations, and personal preferences.
  • The long-term outcomes and comparative effectiveness of CPM versus surveillance or other interventions require further elucidation.

Outlook:

  • Future research should focus on long-term survival data and quality-of-life metrics following CPM.
  • Developing standardized guidelines for patient counseling on CPM and alternative strategies is essential.
  • Further investigation into the psychological and socioeconomic factors influencing CPM decisions is warranted.